Archive for September, 2014« Previous Entries
Tuesday, September 30th, 2014
In response to rising Ebola cases in West Africa, the US Food and Drug Administration (FDA) has approved an emergency treatment drug for the viral infection.
TKM-Ebola by Tekmira has been approve for emergency, limited use in select Ebola patients. The drug is still undergoing research, but it has been approved as a joint effort between [...]
Sunday, September 28th, 2014
Over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAID) are often taken by people when they have headache or acute pain. However, a study indicates that these NSAIDs may come with a greater risk of blood clots that break loose, known as venous thromboembolisms (VTEs).
This link between NSAIDs and VTEs has been largely unexplored until now. The study [...]
Saturday, September 27th, 2014
The US Food and Drug Administration (FDA) has approved Humira (adalimumab) for the treatment of pediatric Crohn’s disease. The medication is the first treatment for Crohn’s disease in children approved for use at home.
Humira has been approved for treating moderate Crohn’s disease patients 6-17 years old.Jeffrey S. Hyams, MD, head of the Division of Digestive [...]
Thursday, September 25th, 2014
As the infection season begins in the US, the Centers for Disease Control and Prevention (CDC) has released the latest case numbers that indicate that enterovirus D68 (EV-D68) infections are rising.
The CDC’s numbers cover the period from mid-August 2014 to 24 September, during which 220 people from 32 US states developed EV-D68-caused respiratory illnesses. Only [...]
Wednesday, September 24th, 2014
Social anxiety disorder is often treated using anti-depressants, but a new study suggests that cognitive behavioral therapy (CBT) may be a more effective approach with longer-term results.
The study was led by Evan Mayo-Wilson, DPhil, of the Johns Hopkins Bloomberg School of Public Health. It assessed the efficacy of various social anxiety disorder treatments, including different [...]
Tuesday, September 23rd, 2014
A recent study has found that while working longer hours may get bigger paychecks, it will also increase the risk of type 2 diabetes.
The study was a review of previous studies that looked at how working overtime affected the health of people of various socioeconomic statuses.
The study was led by Mika Kivimaki, PhD, of University [...]
Sunday, September 21st, 2014
The Centers for Disease Control and Prevention (CDC) has reported that deaths due to opiod overdose rose dramatically in 1999-2006.Opiods are a class of medication with a chemical formula like morphine. The CDC report was written by Li-Hui Chen, PhD, and colleagues.
Leonard Paulozzi, MD, a medical epidemiologist with the CDC’s National Center for Injury Prevention [...]
Saturday, September 20th, 2014
The US Food and Drug Administration (FDA) has approved a new drug with the brand name Trulicity to treat type 2 diabetes. Trulicity is an injection with a recommended dosage frequency of once per week.
Mary Parks, MD, deputy director of the FDA’s Office of Drug Evaluation II, said, “Type 2 diabetes is a serious chronic [...]
Friday, September 19th, 2014
A recent study found that some school districts were unprepared for emergencies associated with asthma, allergies and other chronic conditions. The authors of this study suggested the districts to prepare more health management plans.
The study was led by Ruchi Gupta, MD, of the Northwestern University Feinberg School of Medicine in Chicago. It found that only [...]
Wednesday, September 17th, 2014
According to a new Mayo Clinic study, the rising number of cases of obesity is leading to a rise in number of children suffering from gallstones.
The study was led by Michael Ishitani, MD and looked at the how children coped up with gallstone removal surgery.
Gallstones are often the result of sickle cell disease. They are [...]